Over the past five years, the infection rates for MRSA, or methicillin-resistant staphylococcus aureus, have doubled. Yet, we know that cannabinoids can help address this serious health threat. In fact, the scientific proof is stunning! (a perfectly safe solution is available – now)
According to the Centers for Disease Control and Prevention (CDC), MRSA affects 94,000 Americans each year, and claims the lives of over 18,000 – a grim testimony to the ability of bacteria to mutate and become impervious to antibiotics that were formerly effective. With researchers scrambling to discover novel ways of combatting drug-resistant pathogens – new research offers hope.
Recent studies have shown that the constituents found in medical cannabis can aggressively combat the MRSA pathogen.
Cannabis contains over 70 therapeutic cannabinoids
Cannabinoids (CBD) are fatty acids that occur naturally in the cannabis sativa plant. They are also found naturally – in the form of endocannabinoids – inside the human body, where they help govern immune function, appetite, sleep, memory, cognition and the perception of pain.
Researchers have long known of the antibacterial properties of cannabis. Preparations from cannabis were investigated in the 1950’s as highly active topical antiseptic agents for the mouth and skin.
Research has now progressed to the point where scientists can identify specific cannabinoids, and their effects. And, although the U.S. federal government views cannabis as illegal – cannabinoids are showing great therapeutic potential in pre-clinical trials.
